ES2118255T3 - Agente para uso como antiirritante. - Google Patents

Agente para uso como antiirritante.

Info

Publication number
ES2118255T3
ES2118255T3 ES93920565T ES93920565T ES2118255T3 ES 2118255 T3 ES2118255 T3 ES 2118255T3 ES 93920565 T ES93920565 T ES 93920565T ES 93920565 T ES93920565 T ES 93920565T ES 2118255 T3 ES2118255 T3 ES 2118255T3
Authority
ES
Spain
Prior art keywords
pct
date sep
itching
sec
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93920565T
Other languages
English (en)
Inventor
Gerard Frans Maria Cauwenbergh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2118255T3 publication Critical patent/ES2118255T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Abstract

EL USO DE UN COMPUESTO DE LA FORMULA (I), O DE UN TIPO DE SAL DE ADICION ACIDA COSMETICAMENTE ACEPTABLE DEL MISMO, PARA PREVENIR O REDUCIR LAS IRRITACIONES O LA PICAZON DE LA PIEL DE SERES HUMANOS; COMPOSICIONES COSMETICAS QUE CONTIENEN DICHOS AGENTES, PROCESOS PARA LA PREPARACION DE DICHAS COMPOSICIONES Y UN METODO PARA PREVENIR O REDUCIR LAS IRRITACIONES O LA PICAZON DE LA PIEL DE SERES HUMANOS.
ES93920565T 1992-03-23 1993-03-16 Agente para uso como antiirritante. Expired - Lifetime ES2118255T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200828 1992-03-23

Publications (1)

Publication Number Publication Date
ES2118255T3 true ES2118255T3 (es) 1998-09-16

Family

ID=8210497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93920565T Expired - Lifetime ES2118255T3 (es) 1992-03-23 1993-03-16 Agente para uso como antiirritante.

Country Status (18)

Country Link
US (1) US5476853A (es)
EP (1) EP0632717B1 (es)
JP (1) JPH07504905A (es)
KR (1) KR100234627B1 (es)
AT (1) ATE168004T1 (es)
AU (1) AU665816B2 (es)
CA (1) CA2132528C (es)
CY (1) CY2133B1 (es)
DE (1) DE69319589T2 (es)
DK (1) DK0632717T3 (es)
ES (1) ES2118255T3 (es)
HK (1) HK1010343A1 (es)
IL (1) IL105122A (es)
MX (1) MX9301627A (es)
SG (1) SG48748A1 (es)
TW (1) TW248530B (es)
WO (1) WO1993018744A1 (es)
ZA (1) ZA932025B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403451D0 (en) * 1994-02-23 1994-04-13 Ciba Geigy Ag Sunscreen compositions
US5614511A (en) * 1996-03-11 1997-03-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for treating itchy skin
US5670142A (en) * 1996-07-08 1997-09-23 Donald Neudecker Treatment for itch of chicken pox
CA2329252A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals Inc. Compositions and methods for topical delivery of oligonucleotides
CA2357516A1 (en) * 2000-09-28 2002-03-28 Uni-Charm Corporation Absorbent article and barrier agent for absorbent article
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
WO2014078868A1 (en) * 2012-11-19 2014-05-22 The Trustees Of Columbia University In The City Of New York Methods of treatment of keratinocyte-derived lesions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
DE2436883C2 (de) * 1974-07-29 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
YU39992B (en) * 1976-04-02 1985-06-30 Janssen Pharmaceutica Nv Process for obtaining new piperazine and piperidine derivatives
US4250176A (en) * 1976-12-21 1981-02-10 Janssen Pharmaceutica N.V. Piperazine derivatives
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4377578A (en) * 1976-12-21 1983-03-22 Janssen Pharmaceutica, N.V. Piperazine derivatives
IE68935B1 (en) * 1990-06-22 1996-07-24 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.

Also Published As

Publication number Publication date
IL105122A0 (en) 1993-07-08
CY2133B1 (en) 2002-06-21
JPH07504905A (ja) 1995-06-01
ZA932025B (en) 1994-09-22
KR950700050A (ko) 1995-01-16
US5476853A (en) 1995-12-19
SG48748A1 (en) 1998-05-18
WO1993018744A1 (en) 1993-09-30
AU3749893A (en) 1993-10-21
AU665816B2 (en) 1996-01-18
KR100234627B1 (ko) 1999-12-15
EP0632717B1 (en) 1998-07-08
DE69319589T2 (de) 1998-11-26
HK1010343A1 (en) 1999-06-17
EP0632717A1 (en) 1995-01-11
CA2132528C (en) 2004-06-08
TW248530B (es) 1995-06-01
MX9301627A (es) 1994-07-29
DK0632717T3 (da) 1999-02-22
CA2132528A1 (en) 1993-09-30
IL105122A (en) 1998-06-15
ATE168004T1 (de) 1998-07-15
DE69319589D1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
DE69104723D1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
ATE277588T1 (de) Sprühbare zubereitungen enthaltend dispernierten pulvers sowie dessen anwendungsverfahren
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
CA2120531A1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinoides
KR930702954A (ko) 조성물
OA09877A (fr) Compositions cosmétiques contenant un extrait d'eclipta alba
ES2118255T3 (es) Agente para uso como antiirritante.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
DE69315836D1 (de) Pyrazolpyridine für die behandlung der anämie
JP2006507317A (ja) ベンゾピラン類を用いて毛成長を刺激する方法
ES2104938T3 (es) Metodo de inhibir la fibrosis.
TR199801398T2 (xx) Ast�m� tedavi edici maddeler
KR930701976A (ko) 알칸 아미도 암모늄 화합물의 신규용도
DE69940713D1 (de) Abgabesysteme für aktive Bestandteile die eine Salicylsäurederivat-Zusammensetzung auf einem Film enthalten und ihre Verwendung
ES2058097T3 (es) Agente antibacterial para su uso en mamiferos y que comprende derivados de cefalosporina como ingrediente activo.
ATE120464T1 (de) Acylaminoalkylidenhydroxybisphosphonsäure brauchbar in der therapie von osteoartikularen krankheiten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 632717

Country of ref document: ES